GeneDx (WGS) News Today $100.59 -2.60 (-2.52%) Closing price 04:00 PM EasternExtended Trading$101.75 +1.16 (+1.15%) As of 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Emerald Advisers LLC Makes New $7.06 Million Investment in GeneDx Holdings Corp. (NASDAQ:WGS)Emerald Advisers LLC bought a new stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 91,818 shares of the company's stock, valued at approximately $7,057,000. Emerald AdviMarch 24 at 7:17 AM | marketbeat.com2,720 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Victory Capital Management Inc.Victory Capital Management Inc. bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,720 shares of the company's stock, valued aMarch 24 at 3:14 AM | marketbeat.comIs GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now?March 22 at 10:21 PM | msn.comGeneDx (NASDAQ:WGS) Stock Price Up 4% - Still a Buy?GeneDx (NASDAQ:WGS) Trading Up 4% - What's Next?March 22 at 3:11 PM | marketbeat.comRoyce & Associates LP Buys 3,274 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Royce & Associates LP increased its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 11.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,567 shares of the company's stock after acquiring an additional 3,274 sMarch 22 at 4:09 AM | marketbeat.comCharles Schwab Investment Management Inc. Has $11.64 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS)Charles Schwab Investment Management Inc. increased its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 151,403 shares of the comMarch 22 at 3:10 AM | marketbeat.comGeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 20, 2025 | businesswire.comBank of New York Mellon Corp Purchases 8,597 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Bank of New York Mellon Corp lifted its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 26.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,914 shares of the company's stock after buMarch 20, 2025 | marketbeat.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells 402 Shares of StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 402 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $90.05, for a total value of $36,200.10. Following the completion of the transaction, the chief financial officer now owns 5,044 shares in the company, valued at approximately $454,212.20. The trade was a 7.38 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.March 18, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 1,078 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 1,078 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $89.44, for a total transaction of $96,416.32. Following the completion of the transaction, the chief executive officer now directly owns 6,674 shares in the company, valued at approximately $596,922.56. The trade was a 13.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.March 18, 2025 | marketbeat.comKevin Feeley Sells 3,749 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 3,749 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $96.71, for a total transaction of $362,565.79. Following the sale, the chief financial officer now owns 8,492 shares of the company's stock, valued at approximately $821,261.32. This represents a 30.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.March 18, 2025 | marketbeat.comKatherine Stueland Sells 10,559 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 10,559 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $96.71, for a total value of $1,021,160.89. Following the completion of the sale, the chief executive officer now owns 14,865 shares in the company, valued at $1,437,594.15. This represents a 41.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.March 18, 2025 | marketbeat.comBTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)March 18, 2025 | markets.businessinsider.comIs Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)?March 18, 2025 | finance.yahoo.comFast Company Recognizes GeneDx as One of the World's Most Innovative CompaniesMarch 18, 2025 | businesswire.comWilliam Blair Investment Management LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)William Blair Investment Management LLC purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 669,995 shares of the company's stock, valMarch 18, 2025 | marketbeat.comKevin Feeley Sells 402 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 402 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $90.05, for a total value of $36,200.10. Following the completion of the sale, the chief financial officer now owns 5,044 shares of the company's stock, valued at approximately $454,212.20. The trade was a 7.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.March 18, 2025 | marketbeat.comBrokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Target Price at $72.33March 18, 2025 | americanbankingnews.comRaymond James Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)Raymond James Financial Inc. acquired a new stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 265,045 shares of the company's stock, valued at approximateMarch 17, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Purchases 106,089 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Connor Clark & Lunn Investment Management Ltd. boosted its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 176.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 166,094 shares of the company's stock after purMarch 16, 2025 | marketbeat.com3,501 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Arizona State Retirement SystemArizona State Retirement System acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,501 shares of the company's stMarch 16, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Up 9.2% - Here's What HappenedGeneDx (NASDAQ:WGS) Trading 9.2% Higher - Should You Buy?March 15, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and three have given a buyMarch 15, 2025 | marketbeat.com12 Best Multibagger Stocks to Buy in 2025March 13, 2025 | insidermonkey.comIs GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025?March 13, 2025 | insidermonkey.comGeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual MeetingMarch 13, 2025 | businesswire.comGeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical AnalysisMarch 13, 2025 | businesswire.comKevin Feeley Sells 922 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 922 shares of GeneDx stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $94.72, for a total value of $87,331.84. Following the sale, the chief financial officer now directly owns 5,446 shares in the company, valued at approximately $515,845.12. This trade represents a 14.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 12, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 2,731 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 2,731 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $94.73, for a total value of $258,707.63. Following the completion of the transaction, the chief executive officer now owns 7,752 shares in the company, valued at approximately $734,346.96. The trade was a 26.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.March 12, 2025 | marketbeat.comGeneDx Holdings: There Is Upside Potential, But Price Tag Is RichMarch 12, 2025 | seekingalpha.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $87,331.84 in StockMarch 12, 2025 | insidertrades.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSMarch 11, 2025 | prnewswire.comIs GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now?March 10, 2025 | msn.comLisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS)Lisanti Capital Growth LLC raised its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 85.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 67,900 shares of the company's stock after acquiring an additional 31,285 shares duMarch 8, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Down 6.2% - Here's What HappenedGeneDx (NASDAQ:WGS) Stock Price Down 6.2% - Here's WhyMarch 7, 2025 | marketbeat.com5,000 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Mission Wealth Management LPMission Wealth Management LP bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 5,000 shares of the company's stock, valued at approximately $384March 6, 2025 | marketbeat.comBailard Inc. Takes $277,000 Position in GeneDx Holdings Corp. (NASDAQ:WGS)Bailard Inc. bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,600 shares of the company's stock, valued at apMarch 6, 2025 | marketbeat.comGeneDx management to meet with Craig-HallumMarch 4, 2025 | markets.businessinsider.comGeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New IndicationMarch 4, 2025 | uk.finance.yahoo.comGeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short InterestGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 2,750,000 shares, an increase of 28.5% from the January 31st total of 2,140,000 shares. Based on an average daily volume of 925,000 shares, the days-to-cover ratio is currently 3.0 days. Currently, 11.4% of the company's shares are sold short.March 4, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp - WGSMarch 3, 2025 | prnewswire.comIeq Capital LLC Acquires Shares of 2,857 GeneDx Holdings Corp. (NASDAQ:WGS)Ieq Capital LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 2,857 shares of the company's stock, valued at approximately $220,000.March 2, 2025 | marketbeat.comGuru Fundamental Report for WGS - Benjamin GrahamMarch 1, 2025 | nasdaq.comNew York State Common Retirement Fund Buys 52,843 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)New York State Common Retirement Fund raised its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 347.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,072 shares of the compFebruary 28, 2025 | marketbeat.comGeneDx Holdings (WGS) Gets a Buy from Craig-HallumFebruary 26, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSFebruary 25, 2025 | prnewswire.comBTIG Keeps Their Buy Rating on GeneDx Holdings (WGS)February 25, 2025 | markets.businessinsider.comGeneDx announces publication of research from Seqfirst-neo studyFebruary 24, 2025 | markets.businessinsider.comThompson Davis & CO. Inc. Acquires 6,530 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Thompson Davis & CO. Inc. increased its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 44.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,130 shares of the company's stock aFebruary 23, 2025 | marketbeat.comLegacy Capital Group California Inc. Makes New $883,000 Investment in GeneDx Holdings Corp. (NASDAQ:WGS)Legacy Capital Group California Inc. acquired a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 11,492 shares of the company's stock, valuedFebruary 22, 2025 | marketbeat.com Remove Ads Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address WGS Media Mentions By Week WGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼1.080.62▲Average Medical News Sentiment WGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼146▲WGS Articles Average Week Remove Ads Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIMS News Today OPCH News Today GH News Today RDNT News Today SHC News Today SGRY News Today BTSG News Today PRVA News Today CON News Today LFST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WGS Stock Free WGS Stock Alerts